e-learning
resources
Milan 2017
Monday, 11.09.2017
New insights into pathogenesis of lung disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant
S. Orgeig (Adelaide, SA, Australia)
Source:
International Congress 2017 – New insights into pathogenesis of lung disease
Session:
New insights into pathogenesis of lung disease
Session type:
Poster Discussion
Number:
2029
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Orgeig (Adelaide, SA, Australia). Changes in lipid metabolism in mucopolysaccharidosis (MPS) IIIA mouse lung tissue and pulmonary surfactant. 2029
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Risk factors associated with the development of interstitial lung abnormalities
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Pathology of ILDs
Related content which might interest you:
Collagen I, III and IV content in airways and lung parenchyma of COPD patients
Source: Annual Congress 2010 - Proteases and the matrix
Year: 2010
Increased urotensin II in BALF and lung tissue in rat model of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 216s
Year: 2006
Cellular origin of pro-coagulant and (anti)-fibrinolytic factors in bleomycin-injured lungs
Source: Eur Respir J 2007; 29: 1105-1114
Year: 2007
Complex restrictive pulmonary function pattern in connective tissue disorders (CTD) with interstitial lung disease (ILD)
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
Collagen type III content in large airways and distal lung of fatal asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005
Collagen content in human pulmonary emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 250s
Year: 2001
Scleroderma lung disease: A scleroderma physiologic index (SPI) derived from lung physiology and oxygen saturation
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
Transplant of alveolar type II cells restore pulmonary surfactant in lung fibrosis
Source: Annual Congress 2010 - Stem cells and growth factors in lung injury
Year: 2010
Decreased VEGF concentration in lung tissue and vascular injury during ARDS
Source: Eur Respir J 2005; 25: 139-146
Year: 2005
Abnormal collagen type V deposition in lung fibroblast is correlated with a worse pulmonary function in systemic sclerosis
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007
Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016
Type V collagen induced pulmonary fibrosis in C57Bl/6mice
Source: International Congress 2014 – ILDs: connective tissue disease
Year: 2014
Pulmonary function and exercise tolerance in glycogenosis type II (GSDII)
Source: Annual Congress 2011 - Monitoring with lung function tests in airway diseases
Year: 2011
Pertechnegas lung clearance in different forms of interstitial lung disease
Source: Eur Respir J 2002; 19: 31-36
Year: 2002
Imbalance of glutathione metabolism in type II pneumocytes after NO
2
induced acute and chronic lung injury
Source: Eur Respir J 2004; 24: Suppl. 48, 108s
Year: 2004
Modulation of surfactant metabolism in type II cells from injured lungs by TNF-α and IL-10
Source: Eur Respir J 2003; 22: Suppl. 45, 78s
Year: 2003
Lipid serum profile and copper content in serum and pulmonary tissue in experimental pulmonary emphysema
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010
Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
Regulation, cell-specific expression and metabolism of factor VII activating protease (FSAP) in lungs from patients with acute respiratory distress syndrome (ARDS) and idiopathic pulmonary fibrosis (IPF)
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Defective surfactant biosynthesis and ultrastructural abnormalities of alveolar type 2 cells in pulmonary fibrosis of conditional Nedd4-2mice
Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept